{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T03:12:34Z","timestamp":1788318754632,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-025-01788-6","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T08:44:47Z","timestamp":1750063487000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Independent validation and outlier analysis of EuroPOND Alzheimer\u2019s disease staging model using ADNI and real-world clinical data"],"prefix":"10.1186","volume":"17","author":[{"given":"Mandy M. J.","family":"Wittens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M.","family":"Sima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Brys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Struyfs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellis","family":"Niemantsverdriet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"De Roeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bastin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Bergmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Bier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Paul","family":"de Deyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Deryck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Hanseeuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Ivanoiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00ebtane","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Segers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Sieben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evert","family":"Thiery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos","family":"Tournoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"van Binst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Versijpt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Smeets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bjerke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Bellio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil P.","family":"Oxtoby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemie","family":"Ribbens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiaan","family":"Engelborghs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"issue":"1","key":"1788_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","volume":"18","author":"GBDD Collaborators","year":"2019","unstructured":"Collaborators GBDD. Global, regional, and National burden of alzheimer\u2019s disease and other dementias, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(1):88\u2013106.","journal-title":"Lancet Neurol"},{"issue":"3","key":"1788_CR2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):280\u201392.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1788_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13195-018-0459-7","volume":"11","author":"L Parnetti","year":"2019","unstructured":"Parnetti L, Chipi E, Salvadori N, D\u2019Andrea K, Eusebi P. Prevalence and risk of progression of preclinical alzheimer\u2019s disease stages: a systematic review and meta-analysis. Alzheimers Res Ther. 2019;11(1):7.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"1788_CR4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13195-019-0525-9","volume":"11","author":"D Bertens","year":"2019","unstructured":"Bertens D, Vos S, Kehoe P, Wolf H, Nobili F, Mendon\u00e7a A, et al. Use of mild cognitive impairment and prodromal AD\/MCI due to AD in clinical care: a European survey. Alzheimers Res Ther. 2019;11(1):74.","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"1788_CR5","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/joim.12816","volume":"284","author":"K Blennow","year":"2018","unstructured":"Blennow K, Zetterberg H. Biomarkers for alzheimer\u2019s disease: current status and prospects for the future. J Intern Med. 2018;284(6):643\u201363.","journal-title":"J Intern Med"},{"key":"1788_CR6","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3389\/fneur.2017.00102","volume":"8","author":"RA Huynh","year":"2017","unstructured":"Huynh RA, Mohan C. Alzheimer\u2019s disease: biomarkers in the genome, blood, and cerebrospinal fluid. Front Neurol. 2017;8:102.","journal-title":"Front Neurol"},{"issue":"11","key":"1788_CR7","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S1474-4422(20)30314-8","volume":"19","author":"G Chetelat","year":"2020","unstructured":"Chetelat G, Arbizu J, Barthel H, Garibotto V, Law I, Morbelli S, et al. Amyloid-PET and (18)F-FDG-PET in the diagnostic investigation of alzheimer\u2019s disease and other dementias. Lancet Neurol. 2020;19(11):951\u201362.","journal-title":"Lancet Neurol"},{"issue":"1","key":"1788_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3233\/ADR-170013","volume":"1","author":"N Sheikh-Bahaei","year":"2017","unstructured":"Sheikh-Bahaei N, Sajjadi SA, Manavaki R, Gillard JH. Imaging biomarkers in alzheimer\u2019s disease: A practical guide for clinicians. J Alzheimers Dis Rep. 2017;1(1):71\u201388.","journal-title":"J Alzheimers Dis Rep"},{"issue":"1","key":"1788_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","volume":"9","author":"CR Jack Jr","year":"2010","unstructured":"Jack CR Jr., Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, et al. Hypothetical model of dynamic biomarkers of the alzheimer\u2019s pathological cascade. Lancet Neurol. 2010;9(1):119\u201328.","journal-title":"Lancet Neurol"},{"issue":"2","key":"1788_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack Jr","year":"2013","unstructured":"Jack CR Jr., Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, et al. Tracking pathophysiological processes in alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12(2):207\u201316.","journal-title":"Lancet Neurol"},{"issue":"8","key":"1788_CR11","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr","year":"2024","unstructured":"Jack CR Jr., Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A, et al. Revised criteria for diagnosis and staging of alzheimer\u2019s disease: alzheimer\u2019s association workgroup. Alzheimers Dement. 2024;20(8):5143\u201369.","journal-title":"Alzheimers Dement"},{"issue":"5","key":"1788_CR12","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","volume":"87","author":"CR Jack Jr","year":"2016","unstructured":"Jack CR Jr., Bennett DA, Blennow K, Carrillo MC, Feldman HH, Frisoni GB, et al. A\/T\/N: an unbiased descriptive classification scheme for alzheimer disease biomarkers. Neurology. 2016;87(5):539\u201347.","journal-title":"Neurology"},{"issue":"4","key":"1788_CR13","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr., Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362.","journal-title":"Alzheimers Dement"},{"issue":"6","key":"1788_CR14","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1002\/alz.12906","volume":"19","author":"D Aguillon","year":"2023","unstructured":"Aguillon D, Langella S, Chen Y, Sanchez JS, Su Y, Vila-Castelar C, et al. Plasma p-tau217 predicts in vivo brain pathology and cognition in autosomal dominant alzheimer\u2019s disease. Alzheimers Dement. 2023;19(6):2585\u201394.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1788_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41398-024-03084-7","volume":"14","author":"C Della Monica","year":"2024","unstructured":"Della Monica C, Revell V, Atzori G, Laban R, Skene SS, Heslegrave A, et al. P-tau217 and other blood biomarkers of dementia: variation with time of day. Transl Psychiatry. 2024;14(1):373.","journal-title":"Transl Psychiatry"},{"issue":"3","key":"1788_CR16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","volume":"81","author":"NJ Ashton","year":"2024","unstructured":"Ashton NJ, Brum WS, Di Molfetta G, Benedet AL, Arslan B, Jonaitis E, et al. Diagnostic accuracy of a plasma phosphorylated Tau 217 immunoassay for alzheimer disease pathology. JAMA Neurol. 2024;81(3):255\u201363.","journal-title":"JAMA Neurol"},{"issue":"11","key":"1788_CR17","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1586\/ern.11.155","volume":"11","author":"S Karantzoulis","year":"2011","unstructured":"Karantzoulis S, Galvin JE. Distinguishing alzheimer\u2019s disease from other major forms of dementia. Expert Rev Neurother. 2011;11(11):1579\u201391.","journal-title":"Expert Rev Neurother"},{"issue":"4","key":"1788_CR18","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1007\/s00415-019-09679-1","volume":"267","author":"G Wei","year":"2020","unstructured":"Wei G, Irish M, Hodges JR, Piguet O, Kumfor F. Disease-specific profiles of apathy in alzheimer\u2019s disease and behavioural-variant frontotemporal dementia differ across the disease course. J Neurol. 2020;267(4):1086\u201396.","journal-title":"J Neurol"},{"key":"1788_CR19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neuroimage.2016.03.032","volume":"151","author":"R Landin-Romero","year":"2017","unstructured":"Landin-Romero R, Kumfor F, Leyton CE, Irish M, Hodges JR, Piguet O. Disease-specific patterns of cortical and subcortical degeneration in a longitudinal study of alzheimer\u2019s disease and behavioural-variant frontotemporal dementia. NeuroImage. 2017;151:72\u201380.","journal-title":"NeuroImage"},{"key":"1788_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2019.10.020","volume":"87","author":"BS Ye","year":"2020","unstructured":"Ye BS, Lee S, Yoo H, Chung SJ, Lee YH, Choi Y, et al. Distinguishing between dementia with lewy bodies and alzheimer\u2019s disease using metabolic patterns. Neurobiol Aging. 2020;87:11\u20137.","journal-title":"Neurobiol Aging"},{"key":"1788_CR21","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.neuroimage.2018.11.024","volume":"186","author":"V Venkatraghavan","year":"2019","unstructured":"Venkatraghavan V, Bron EE, Niessen WJ, Klein S. Alzheimer\u2019s disease neuroimaging I. disease progression timeline Estimation for alzheimer\u2019s disease using discriminative event based modeling. NeuroImage. 2019;186:518\u201332.","journal-title":"NeuroImage"},{"issue":"3","key":"1788_CR22","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1016\/j.neuroimage.2012.01.062","volume":"60","author":"HM Fonteijn","year":"2012","unstructured":"Fonteijn HM, Modat M, Clarkson MJ, Barnes J, Lehmann M, Hobbs NZ, et al. An event-based model for disease progression and its application in Familial alzheimer\u2019s disease and huntington\u2019s disease. NeuroImage. 2012;60(3):1880\u20139.","journal-title":"NeuroImage"},{"key":"1788_CR23","doi-asserted-by":"publisher","first-page":"11934","DOI":"10.1038\/ncomms11934","volume":"7","author":"Y Iturria-Medina","year":"2016","unstructured":"Iturria-Medina Y, Sotero RC, Toussaint PJ, Mateos-P\u00e9rez JM, Evans AC. Early role of vascular dysregulation on late-onset alzheimer\u2019s disease based on multifactorial data-driven analysis. Nat Commun. 2016;7:11934.","journal-title":"Nat Commun"},{"issue":"2","key":"1788_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41583-023-00779-6","volume":"25","author":"AL Young","year":"2024","unstructured":"Young AL, Oxtoby NP, Garbarino S, Fox NC, Barkhof F, Schott JM, et al. Data-driven modelling of neurodegenerative disease progression: thinking outside the black box. Nat Rev Neurosci. 2024;25(2):111\u201330.","journal-title":"Nat Rev Neurosci"},{"key":"1788_CR25","doi-asserted-by":"publisher","first-page":"101954","DOI":"10.1016\/j.nicl.2019.101954","volume":"24","author":"D Archetti","year":"2019","unstructured":"Archetti D, Ingala S, Venkatraghavan V, Wottschel V, Young AL, Bellio M, et al. Multi-study validation of data-driven disease progression models to characterize evolution of biomarkers in alzheimer\u2019s disease. Neuroimage Clin. 2019;24:101954.","journal-title":"Neuroimage Clin"},{"issue":"Pt 9","key":"1788_CR26","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1093\/brain\/awu176","volume":"137","author":"AL Young","year":"2014","unstructured":"Young AL, Oxtoby NP, Daga P, Cash DM, Fox NC, Ourselin S, et al. A data-driven model of biomarker changes in sporadic alzheimer\u2019s disease. Brain. 2014;137(Pt 9):2564\u201377.","journal-title":"Brain"},{"key":"1788_CR27","doi-asserted-by":"publisher","first-page":"661110","DOI":"10.3389\/fdata.2021.661110","volume":"4","author":"D Archetti","year":"2021","unstructured":"Archetti D, Young AL, Oxtoby NP, Ferreira D, Martensson G, Westman E, et al. Inter-Cohort validation of sustain model for alzheimer\u2019s disease. Front Big Data. 2021;4:661110.","journal-title":"Front Big Data"},{"key":"1788_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.dadm.2019.01.005","volume":"11","author":"M Bilgel","year":"2019","unstructured":"Bilgel M, Jedynak BM. Predicting time to dementia using a quantitative template of disease progression. Alzheimers Dement (Amst). 2019;11:205\u201315.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"1","key":"1788_CR29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13195-020-00695-2","volume":"12","author":"A O\u2019Connor","year":"2020","unstructured":"O\u2019Connor A, Weston PSJ, Pavisic IM, Ryan NS, Collins JD, Lu K, et al. Quantitative detection and staging of presymptomatic cognitive decline in Familial alzheimer\u2019s disease: a retrospective cohort analysis. Alzheimers Res Ther. 2020;12(1):126.","journal-title":"Alzheimers Res Ther"},{"issue":"10","key":"1788_CR30","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1038\/s41591-022-01942-9","volume":"28","author":"AM Staffaroni","year":"2022","unstructured":"Staffaroni AM, Quintana M, Wendelberger B, Heuer HW, Russell LL, Cobigo Y, et al. Temporal order of clinical and biomarker changes in Familial frontotemporal dementia. Nat Med. 2022;28(10):2194\u2013206.","journal-title":"Nat Med"},{"key":"1788_CR31","first-page":"1","volume":"1","author":"PA Wijeratne","year":"2023","unstructured":"Wijeratne PA, Eshaghi A, Scotton WJ, Kohli M, Aksman L, Oxtoby NP, et al. The Temporal event-based model: learning event timelines in progressive diseases. Imaging Neurosci (Camb). 2023;1:1\u201319.","journal-title":"Imaging Neurosci (Camb)"},{"issue":"2","key":"1788_CR32","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3233\/JAD-170327","volume":"60","author":"E Niemantsverdriet","year":"2017","unstructured":"Niemantsverdriet E, Ottoy J, Somers C, De Roeck E, Struyfs H, Soetewey F, et al. The cerebrospinal fluid Abeta1-42\/Abeta1-40 ratio improves concordance with Amyloid-PET for diagnosing alzheimer\u2019s disease in a clinical setting. J Alzheimers Dis. 2017;60(2):561\u201376.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"1788_CR33","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3233\/JAD-210450","volume":"83","author":"MMJ Wittens","year":"2021","unstructured":"Wittens MMJ, Sima DM, Houbrechts R, Ribbens A, Niemantsverdriet E, Fransen E, et al. Diagnostic performance of automated MRI volumetry by icobrain Dm for alzheimer\u2019s disease in a clinical setting: A REMEMBER study. J Alzheimers Dis. 2021;83(2):623\u201339.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"1788_CR34","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.3233\/JAD-171140","volume":"63","author":"E Niemantsverdriet","year":"2018","unstructured":"Niemantsverdriet E, Ribbens A, Bastin C, Benoit F, Bergmans B, Bier JC, et al. A retrospective Belgian Multi-Center MRI biomarker study in alzheimer\u2019s disease (REMEMBER). J Alzheimers Dis. 2018;63(4):1509\u201322.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1788_CR35","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13195-024-01491-y","volume":"16","author":"MMJ Wittens","year":"2024","unstructured":"Wittens MMJ, Denissen S, Sima DM, Fransen E, Niemantsverdriet E, Bastin C, et al. Brain age as a biomarker for pathological versus healthy ageing - a REMEMBER study. Alzheimers Res Ther. 2024;16(1):128.","journal-title":"Alzheimers Res Ther"},{"key":"1788_CR36","doi-asserted-by":"publisher","first-page":"102707","DOI":"10.1016\/j.nicl.2021.102707","volume":"31","author":"M Rakic","year":"2021","unstructured":"Rakic M, Vercruyssen S, Van Eyndhoven S, de la Rosa E, Jain S, Van Huffel S, et al. Icobrain Ms 5.1: combining unsupervised and supervised approaches for improving the detection of multiple sclerosis lesions. Neuroimage Clin. 2021;31:102707.","journal-title":"Neuroimage Clin"},{"issue":"4","key":"1788_CR37","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jpsychires.2008.04.014","volume":"43","author":"AJ Mitchell","year":"2009","unstructured":"Mitchell AJ. A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment. J Psychiatr Res. 2009;43(4):411\u201331.","journal-title":"J Psychiatr Res"},{"issue":"1","key":"1788_CR38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13195-016-0176-z","volume":"8","author":"KR Chapman","year":"2016","unstructured":"Chapman KR, Bing-Canar H, Alosco ML, Steinberg EG, Martin B, Chaisson C, et al. Mini mental state examination and logical memory scores for entry into alzheimer\u2019s disease trials. Alzheimers Res Ther. 2016;8(1):9.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"1788_CR39","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/geriatrics8010012","volume":"8","author":"F Salis","year":"2023","unstructured":"Salis F, Costaggiu D, Mandas A. Mini-Mental state examination: optimal Cut-Off levels for mild and severe cognitive impairment. Geriatrics. 2023;8(1):12.","journal-title":"Geriatrics"},{"issue":"11","key":"1788_CR40","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1093\/brain\/awz235","volume":"142","author":"S O\u2019Dowd","year":"2019","unstructured":"O\u2019Dowd S, Schumacher J, Burn DJ, Bonanni L, Onofrj M, Thomas A, et al. Fluctuating cognition in the lewy body dementias. Brain. 2019;142(11):3338\u201350.","journal-title":"Brain"},{"issue":"1","key":"1788_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/brain\/awz311","volume":"143","author":"E Matar","year":"2019","unstructured":"Matar E, Shine JM, Halliday GM, Lewis SJG. Cognitive fluctuations in lewy body dementia: towards a pathophysiological framework. Brain. 2019;143(1):31\u201346.","journal-title":"Brain"},{"issue":"1","key":"1788_CR42","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41531-022-00279-x","volume":"8","author":"E Matar","year":"2022","unstructured":"Matar E, Ehgoetz Martens KA, Phillips JR, Wainstein G, Halliday GM, Lewis SJG, et al. Dynamic network impairments underlie cognitive fluctuations in lewy body dementia. Npj Parkinson\u2019s Disease. 2022;8(1):16.","journal-title":"Npj Parkinson\u2019s Disease"},{"issue":"4","key":"1788_CR43","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/alz.12763","volume":"19","author":"MJ Grothe","year":"2023","unstructured":"Grothe MJ, Moscoso A, Silva-Rodriguez J, Lange C, Nho K, Saykin AJ, et al. Differential diagnosis of amnestic dementia patients based on an FDG-PET signature of autopsy-confirmed LATE-NC. Alzheimers Dement. 2023;19(4):1234\u201344.","journal-title":"Alzheimers Dement"},{"issue":"10","key":"1788_CR44","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1093\/brain\/awae203","volume":"147","author":"L Barba","year":"2024","unstructured":"Barba L, Abu-Rumeileh S, Barthel H, Massa F, Foschi M, Bellomo G, et al. Clinical and diagnostic implications of alzheimer\u2019s disease copathology in lewy body disease. Brain. 2024;147(10):3325\u201343.","journal-title":"Brain"},{"issue":"2","key":"1788_CR45","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/ana.26711","volume":"94","author":"PT Nelson","year":"2023","unstructured":"Nelson PT, Schneider JA, Jicha GA, Duong MT, Wolk DA. When alzheimer\u2019s is LATE: why does it matter?? Ann Neurol. 2023;94(2):211\u201322.","journal-title":"Ann Neurol"},{"issue":"1","key":"1788_CR46","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13195-023-01367-7","volume":"16","author":"A Jannati","year":"2024","unstructured":"Jannati A, Toro-Serey C, Gomes-Osman J, Banks R, Ciesla M, Showalter J, et al. Digital clock and recall is superior to the Mini-Mental state examination for the detection of mild cognitive impairment and mild dementia. Alzheimers Res Ther. 2024;16(1):2.","journal-title":"Alzheimers Res Ther"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01788-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01788-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01788-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T22:10:55Z","timestamp":1757196655000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01788-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1788"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01788-6","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"assertion":[{"value":"18 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The REMEMBER study was approved by the ethics committee of University of Antwerp \/ Universitair Ziekenhuis Antwerpen, Antwerp (N\u00b016\/2\/18) and by the ethics committees of Algemeen Ziekenhuis Sint-Jan Brugge-Oostende, Brugge (N\u00b01992); Centre Hospitalier Universitaire Brugmann (CHU Brugmann), Brussels (N\u00b02016\/84); Centre Hospitalier Universitaire Li\u00e8ge (CHU Li\u00e8ge), Li\u00e8ge (N\u00b02012\/274); Cliniques Universitaires de Bruxelles (ULB), H\u00f4pital Erasme, Brussels (N\u00b0P2016\/187); Cliniques Universitaires Saint-Luc (UCL), Brussels (N\u00b02016\/07jui\/261); Cliniques St-Pierre Ottignies, Ottignies (N\u00b0OM045); Universitair Ziekenhuis Brussel, Brussels (N\u00b02016\/183); and Ziekenhuis Netwerk Antwerp (ZNA), Antwerp (N\u00b04730). The research was conducted in accordance with the Declaration of Helsinki and informed written consent was obtained from all participants from the University of Antwerp prospective research cohort, that was approved by the ethics committee of University of Antwerp \/ Universitair Ziekenhuis Antwerpen, Antwerp (N\u00b015\/38\/394). icobrain dm is a proprietary software, developed by icometrix for the automated quantification of brain volumes and white matter hyperintensities.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"134"}}